Personalis MRD Test Shows Superior Sensitivity in Lung Cancer Trial
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca’s NeoADAURA study.
Read MorePosted by CLP Edit Staff | Sep 3, 2025 | Lung Cancer |
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca’s NeoADAURA study.
Read MorePosted by CLP Edit Staff | Aug 29, 2025 | Uncategorized |
Study demonstrates OneBreath platform can diagnose and predict pneumonia onset in cardiac surgery patients through volatile organic compound detection.
Read MorePosted by CLP Edit Staff | Aug 28, 2025 | Analytical Software Systems |
The expansion adds compatibility with Roche’s VENTANA DP 200 and DP 600 scanners and makes AISight Dx the first digital pathology image management system cleared under the FDA’s Predetermined Change Control Plan.
Read MorePosted by CLP Edit Staff | Aug 19, 2025 | Sequencing Systems |
New whole exome and transcriptome sequencing assay demonstrates high concordance with existing companion diagnostics while requiring minimal tissue input for biomarker detection.
Read MorePosted by CLP Edit Staff | Aug 18, 2025 | Flow Cytometry Reagents & Test Kits |
Company sees back-to-back record months in June and July, reaffirms forecast of 3X year-over-year revenue growth for noninvasive lung cancer diagnostic.
Read More